Virtus ETF Advisers LLC Nektar Therapeutics Transaction History

Virtus ETF Advisers LLC

$234 Million
Q4 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.64 - $3.15 $1,269 - $6,249	1,984 Added 1.8%	112,404 $78,000
Q4 2022 Feb 14, 2023	BUY	$2.03 - $4.28 $77,956 - $164,360	38,402 Added 53.32%	110,420 $249,000
Q3 2022 Nov 14, 2022	BUY	$3.04 - $5.14 $3,204 - $5,417	1,054 Added 1.49%	72,018 $230,000
Q2 2022 Aug 12, 2022	BUY	$3.17 - $6.17 $131,967 - $256,857	41,630 Added 141.92%	70,964 $270,000
Q4 2021 Feb 14, 2022	BUY	$10.83 - $18.41 $37,580 - $63,882	3,470 Added 13.42%	29,334 $396,000
Q3 2021 Nov 15, 2021	SELL	$13.07 - $18.84 $31,067 - $44,782	-2,377 Reduced 8.42%	25,864 $465,000
Q2 2021 Aug 10, 2021	SELL	$16.52 - $20.4 $119,522 - $147,594	-7,235 Reduced 20.39%	28,241 $485,000
Q1 2021 May 17, 2021	BUY	$16.56 - $25.46 $16,112 - $24,772	973 Added 2.82%	35,476 $710,000
Q4 2020 Feb 12, 2021	BUY	$15.77 - $19.03 $94,273 - $113,761	5,978 Added 20.96%	34,503 $587,000
Q3 2020 Nov 13, 2020	BUY	$16.59 - $24.79 $39,865 - $59,570	2,403 Added 9.2%	28,525 $473,000
Q2 2020 Aug 05, 2020	SELL	$16.86 - $23.44 $26,031 - $36,191	-1,544 Reduced 5.58%	26,122 $605,000
Q1 2020 May 14, 2020	SELL	$14.47 - $27.96 $33,772 - $65,258	-2,334 Reduced 7.78%	27,666 $494,000
Q4 2019 Feb 13, 2020	BUY	$15.87 - $23.12 $146,924 - $214,044	9,258 Added 44.63%	30,000 $648,000
Q3 2019 Nov 12, 2019	SELL	$16.91 - $36.27 $63,006 - $135,142	-3,726 Reduced 15.23%	20,742 $378,000
Q2 2019 Aug 13, 2019	BUY	$31.0 - $36.3 $758,508 - $888,188	24,468 New	24,468 $870,000
Q1 2019 May 14, 2019	SELL	$31.58 - $46.35 $524,038 - $769,131	-16,594 Closed	0 $0
Q4 2018 Feb 05, 2019	BUY	$30.43 - $56.65 $82,678 - $153,918	2,717 Added 19.58%	16,594 $545,000
Q3 2018 Nov 14, 2018	BUY	$46.46 - $68.49 $43,440 - $64,038	935 Added 7.22%	13,877 $846,000
Q2 2018 Aug 10, 2018	SELL	$46.25 - $104.45 $95,691 - $216,107	-2,069 Reduced 13.78%	12,942 $632,000
Q1 2018 May 14, 2018	SELL	$57.4 - $108.44 $107,912 - $203,867	-1,880 Reduced 11.13%	15,011 $1.6 Million
Q4 2017 Feb 14, 2018	SELL	$23.02 - $60.5 $903,304 - $2.37 Million	-39,240 Reduced 69.91%	16,891 $1.01 Million
Q2 2017 Aug 14, 2017	BUY	N/A	56,131	56,131 $1.1 Million

Others Institutions Holding NKTR

# of Institutions

152

Shares Held

131M

Call Options Held

92.7K

Put Options Held

4.9K

Black Rock Inc. New York, NY

15.2M
Shares

$14.1 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

12.3M
Shares

$11.5 Million
0.0% of portfolio
Samlyn Capital, LLC New York, NY

9.67M
Shares

$8.99 Million
0.14% of portfolio
Nantahala Capital Management, LLC New Canaan, CT

7.81M
Shares

$7.26 Million
0.37% of portfolio
Acadian Asset Management LLC Boston, MA

7.2M
Shares

$6.7 Million
0.02% of portfolio

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $174M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Account